Exploring androgen receptor signaling pathway in prostate cancer: A path to new discoveries

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Androgen deprivation therapy (ADT) is a cornerstone treatment for prostate cancer, targeting the androgen receptor (AR) signaling pathway.
• The development of castration-resistant prostate cancer (CRPC) signifies a major limitation of ADT, necessitating research into resistance mechanisms.
• Understanding AR-dependent and AR-independent pathways is crucial for overcoming treatment resistance.

Purpose of the Study:

• To review and elucidate the multifaceted mechanisms driving resistance to androgen deprivation therapy in prostate cancer.
• To explore the roles of androgen receptor alterations, glucocorticoid receptor involvement, and coregulator/transcription factor changes in CRPC progression.
• To identify potential new therapeutic targets and personalized treatment strategies for CRPC.

Main Methods:

• Comprehensive literature review focusing on molecular mechanisms of castration-resistant prostate cancer.
• Analysis of studies detailing androgen receptor gene amplification, mutations, splice variants, and their functional consequences.
• Examination of research on the interplay between glucocorticoid receptors, coregulators, and transcription factors in AR signaling and resistance.

Main Results:

• Androgen receptor overexpression, splice variants, and missense mutations contribute to ADT resistance by enhancing AR signaling.
• Amplification and mutations in the AR gene allow for adaptation and survival of cancer cells under treatment pressure.
• Activation of glucocorticoid receptors and dysregulation of coregulators/transcription factors promote AR-independent pathways, driving CRPC cell survival and proliferation.

Conclusions:

• Resistance to ADT in prostate cancer is driven by complex AR-dependent and AR-independent mechanisms.
• Targeting specific molecular alterations in AR signaling and identifying novel pathways are essential for effective CRPC treatment.
• Further research into these mechanisms will pave the way for developing more precise and personalized therapeutic strategies for advanced prostate cancer.